Home > Boards > US Listed > Medical - Equipment > Cytosorbents Corporation (CTSO)

Good Sport--he is not my captain. Proxy vote

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
ranchhand71 Member Profile
 
Followed By 5
Posts 718
Boards Moderated 0
Alias Born 12/22/17
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 6/2/2021 6:01:59 AM
CytoSorbents Appoints Terri Anne Powers, IRC as Vice President of Investor Relations and Corporate Communications PR Newswire (US) - 6/1/2021 7:08:00 AM
CytoSorbents to Present at the Jefferies Virtual Healthcare Conference PR Newswire (US) - 5/27/2021 7:00:00 AM
CytoSorbents' CytoSorb blood purification now available in Singapore Seeking Alpha - 5/25/2021 7:51:17 AM
CytoSorb® Registered and Commercially Available in Singapore PR Newswire (US) - 5/25/2021 7:08:00 AM
CytoSorbents to Present at the UBS Global Healthcare Virtual Conference and Oppenheimer MedTech, Tools and Diagnostic Summit PR Newswire (US) - 5/19/2021 7:00:00 AM
CytoSorbents awarded $1.5M U.S army research and development contract Seeking Alpha - 5/11/2021 9:08:14 AM
CytoSorbents Awarded $1.5 Million Sequential Phase II SBIR Contract to Advance the Treatment of Severe Hyperkalemia in Trauma... PR Newswire (US) - 5/11/2021 8:50:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/5/2021 6:07:06 AM
Cytosorbents EPS misses by $0.05, misses on revenue Seeking Alpha - 5/4/2021 4:33:48 PM
CytoSorbents Reports First Quarter 2021 Financial and Operational Results PR Newswire (US) - 5/4/2021 4:15:00 PM
CytoSorbents to Report Q1 2021 Operating and Financial Results PR Newswire (US) - 4/27/2021 1:55:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/20/2021 4:31:57 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/19/2021 4:31:35 PM
FDA gives green light to CytoSorbents to begin U.S. STAR-T trial for ticagrelor removal Seeking Alpha - 4/19/2021 7:48:55 AM
U.S. FDA Approves CytoSorbents to Initiate U.S. STAR-T Trial For Ticagrelor Removal During Cardiothoracic Surgery PR Newswire (US) - 4/19/2021 7:08:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/15/2021 7:48:37 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/31/2021 4:21:49 PM
CytoSorbents Announces Lease of New Global Headquarters in Princeton, New Jersey PR Newswire (US) - 3/29/2021 7:08:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/17/2021 4:31:50 PM
CytoSorbents Announces Filing of an Investigational Device Exemption (IDE) for U.S. Trial on Ticagrelor Removal During Cardio... PR Newswire (US) - 3/16/2021 3:15:00 PM
CytoSorbents to Present at the Oppenheimer 31st Annual Healthcare Conference PR Newswire (US) - 3/12/2021 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/9/2021 4:31:25 PM
Cytosorbents EPS beats by $0.03, beats on revenue Seeking Alpha - 3/9/2021 4:21:39 PM
CytoSorbents Announces 2020 Financial and Operational Results PR Newswire (US) - 3/9/2021 4:15:00 PM
ranchhand71   Wednesday, 05/12/21 10:39:22 AM
Re: Good Sport post# 26281
Post # of 26412 
Good Sport--he is not my captain. Proxy vote was a chance in a minor way to vote displeasure. Too much pr and not enough meat on the bone.

I actually think he should have put a lot more effort NOW behind HemoDefend as it would appear easier to get approval, the universal blood market among blood centers and other critical locations (submarines, naval ships, cruise ships etc) with 80% gross margins is here and quite large and lower marketing expenses is a huge plus.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences